<DOC>
	<DOCNO>NCT00910598</DOCNO>
	<brief_summary>This study patient clinically isolated syndrome ( CIS ) early relapse remit multiple sclerosis ( RRMS ) ass effect glatiramer acetate ( GA ) subcutaneously condition optical nerve comparison medicinal therapy 12 month assess use Optical Coherence tomography ( OCT ) , non-invasive ophthalmological technique , daily practice alternative magnetic resonance imaging ( MRI ) scan follow-up patient .</brief_summary>
	<brief_title>Optical Coherence Tomography : Glatiramer Clinically Isolated Syndrome Early Relapsing Remitting Multiple Sclerosis ( MS )</brief_title>
	<detailed_description>Multiple sclerosis ( MS ) progressive demyelinate disease central nervous system characterize inflammation neurodegeneration . It characterize ongoing process demyelination axonal loss , even begin disease course , result brain atrophy . A first manifestation clinical definite MS , call clinically isolated syndrome ( CIS ) . Brain atrophy occur even patient CIS . Optic neuritis ( ON ) common feature CIS . The axon retina represent proximal part optic nerve devoid myelin . Because retina part central nervous system ( CNS ) , measurement Retinal Nerve Fiber Layer ( RFLN ) Optical Coherence Tomography ( OCT ) offer opportunity visualize unmyelinated axon CNS directly . OCT non-invasive method measure thickness optical layer . The thickness RNFL reduce MS patient without ON history . Glatiramer acetate ( GA ) , immunomodulatory drug RRMS CIS , reduce brain atrophy stimulate production brain-derived neurotrophic factor , turn could stimulate neuroregeneration . In pilot study would like assess feasibility OCT measurement patient CIS ON Dutch clinical setting assess effect GA RNFL visual function patient CIS early relapse remit MS patient .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>Age : 18 55 year Early relapse remit MS , define disease course le 3 year clinically isolate syndrome , define optic neuritis ( ON ) ON Currently treat glatiramer ( GA ) currently treat MS Expanded disability status scale ( EDSS ) score 05 Able willing provide write informed consent prior enrolment Willing able comply protocol requirement duration study Clinical definite multiple sclerosis disease course 3 year Primary progressive multiple sclerosis Secondary progressive multiple sclerosis Current use approve investigational disease modify agent treatment MS GA. Neuromyelitis Optica ( Devic 's disease ) Any condition may interfere quality OCT scan : clouding medium , i.e . cataract , pupil hard dilate . Contraindications Copaxone Â® define Summary Product Characteristics ( SPC ) text Hypersensitivity GA mannitol Subject 's inability complete study subject consider investigator reason , unsuitable candidate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>clinically isolated syndrome</keyword>
	<keyword>relapse remit multiple sclerosis</keyword>
	<keyword>glatiramer acetate</keyword>
	<keyword>Optical Coherence Tomography</keyword>
</DOC>